$ACU
ACME UNITED CORP

2021 Q4 Form 10-K Financial Statement

#000156459022012597 Filed on March 30, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $45.79M $182.1M $40.87M
YoY Change 12.04% 11.03% 20.66%
Cost Of Revenue $29.74M $117.3M $25.81M
YoY Change 15.2% 12.34% 19.63%
Gross Profit $16.06M $64.80M $15.06M
YoY Change 6.64% 8.74% 22.46%
Gross Profit Margin 35.06% 35.59% 36.84%
Selling, General & Admin $13.00M $52.03M $12.16M
YoY Change 6.94% 7.99% 11.63%
% of Gross Profit 80.98% 80.29% 80.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.129M $2.558M $931.0K
YoY Change 21.22% 5.36% 8.79%
% of Gross Profit 7.03% 3.95% 6.18%
Operating Expenses $13.00M $52.03M $12.16M
YoY Change 6.94% 7.43% 11.63%
Operating Profit $3.053M $12.77M $2.897M
YoY Change 5.4% 11.89% 106.68%
Interest Expense -$237.2K -$908.2K -$197.7K
YoY Change 19.99% -1.25% -39.26%
% of Operating Profit -7.77% -7.11% -6.83%
Other Income/Expense, Net $18.12K $3.313M -$664.2K
YoY Change -102.73% -597.45% 1354.41%
Pretax Income $2.834M $15.18M $2.035M
YoY Change 39.28% 54.42% 97.71%
Income Tax $500.3K $1.519M -$9.040K
% Of Pretax Income 17.65% 10.01% -0.44%
Net Earnings $2.334M $13.66M $2.044M
YoY Change 14.19% 68.61% 108.97%
Net Earnings / Revenue 5.1% 7.5% 5.0%
Basic Earnings Per Share $3.93
Diluted Earnings Per Share $596.2K $3.45 $556.4K
COMMON SHARES
Basic Shares Outstanding 3.471M
Diluted Shares Outstanding 3.955M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.843M $4.843M $4.167M
YoY Change 16.22% 16.22% -38.91%
Cash & Equivalents $4.843M $4.843M $4.167M
Short-Term Investments
Other Short-Term Assets $2.634M $2.634M $1.641M
YoY Change 60.54% 60.54% 3.97%
Inventory $53.55M $53.55M $50.70M
Prepaid Expenses
Receivables $34.22M $34.22M $27.17M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $95.25M $95.25M $83.69M
YoY Change 13.82% 13.82% 14.41%
LONG-TERM ASSETS
Property, Plant & Equipment $24.03M $27.16M $20.24M
YoY Change 18.72% 19.85% 44.2%
Goodwill $4.800M $4.800M
YoY Change 0.0% 2.2%
Intangibles $17.23M $18.72M
YoY Change -7.96% 18.54%
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $49.19M $49.19M $46.18M
YoY Change 6.51% 6.51% 22.82%
TOTAL ASSETS
Total Short-Term Assets $95.25M $95.25M $83.69M
Total Long-Term Assets $49.19M $49.19M $46.18M
Total Assets $144.4M $144.4M $129.9M
YoY Change 11.22% 11.22% 17.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.977M $8.977M $7.601M
YoY Change 18.1% 18.1% 13.57%
Accrued Expenses $9.909M $9.888M $11.46M
YoY Change -13.53% -13.56% 33.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $388.5K $388.5K $266.7K
YoY Change 45.7% 45.7% 0.0%
Total Short-Term Liabilities $20.28M $20.28M $20.20M
YoY Change 0.37% 0.37% 21.82%
LONG-TERM LIABILITIES
Long-Term Debt $33.04M $44.12M $38.77M
YoY Change -14.78% -2.36% 16.63%
Other Long-Term Liabilities $599.0K $2.364M $1.654M
YoY Change -63.79% 42.94% 5020.52%
Total Long-Term Liabilities $33.64M $46.48M $38.77M
YoY Change -13.24% -0.76% 16.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.28M $20.28M $20.20M
Total Long-Term Liabilities $33.64M $46.48M $38.77M
Total Liabilities $67.36M $67.36M $67.15M
YoY Change 0.31% 0.31% 21.99%
SHAREHOLDERS EQUITY
Retained Earnings $69.87M $58.03M
YoY Change 20.4% 12.53%
Common Stock $12.66M $12.10M
YoY Change 4.58% 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost) $16.00M $14.52M
YoY Change 10.15% 2.02%
Treasury Stock Shares $1.545M $3.339M
Shareholders Equity $77.08M $77.08M $62.72M
YoY Change
Total Liabilities & Shareholders Equity $144.4M $144.4M $129.9M
YoY Change 11.22% 11.22% 17.26%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $2.334M $13.66M $2.044M
YoY Change 14.19% 68.61% 108.97%
Depreciation, Depletion And Amortization $1.129M $2.558M $931.0K
YoY Change 21.22% 5.36% 8.79%
Cash From Operating Activities $2.162M $5.141M $3.980M
YoY Change -45.69% -10.15% -46.46%
INVESTING ACTIVITIES
Capital Expenditures -$1.581M $6.373M -$488.2K
YoY Change 223.78% 148.04% -12.43%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$9.309M
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.581M -$6.373M -$9.797M
YoY Change -83.87% -54.32% 1657.35%
FINANCING ACTIVITIES
Cash Dividend Paid $1.792M
YoY Change 11.69%
Common Stock Issuance & Retirement, Net $3.089M
YoY Change 5157.59%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -970.3K 2.043M 6.754M
YoY Change -114.37% -61.39% -216.83%
NET CHANGE
Cash From Operating Activities 2.162M 5.141M 3.980M
Cash From Investing Activities -1.581M -6.373M -9.797M
Cash From Financing Activities -970.3K 2.043M 6.754M
Net Change In Cash -389.4K 676.0K 937.2K
YoY Change -141.55% -125.47% -14.46%
FREE CASH FLOW
Cash From Operating Activities $2.162M $5.141M $3.980M
Capital Expenditures -$1.581M $6.373M -$488.2K
Free Cash Flow $3.742M -$1.232M $4.468M
YoY Change -16.25% -139.09% -44.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0042
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0030
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.00397
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.00358
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0111
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0163
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.00415
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201802Member
CY2020 acu Adjustments To Additional Paid In Capital Cash Settlement Of Stock Options
AdjustmentsToAdditionalPaidInCapitalCashSettlementOfStockOptions
1644118
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
286988
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
778869
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2021 us-gaap Depreciation
Depreciation
2557680
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1259079
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1806758
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8098766
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
77081961
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8098766
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8098766
CY2021 us-gaap Revenues
Revenues
182087559
CY2020 us-gaap Revenues
Revenues
164003040
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117287202
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104408326
CY2021 us-gaap Gross Profit
GrossProfit
64800357
CY2020 us-gaap Gross Profit
GrossProfit
59594714
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52030370
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48182050
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
12769987
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
11412664
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
921965
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
944363
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
13742
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
24654
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-908223
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-919709
CY2021 acu Ppp Loan Forgiveness
PPPLoanForgiveness
3508047
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-194877
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-666227
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3313170
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-666227
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15174934
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9826728
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1519255
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1727962
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.93
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.42
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.45
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8098766
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-554681
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
647632
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
514271
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-554681
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15995622
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3520646
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3338913
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11930067
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1380648
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69873377
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
77081961
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
144438684
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1161903
CY2021Q4 us-gaap Assets Current
AssetsCurrent
95250614
CY2021Q4 us-gaap Land
Land
1761434
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
13455514
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
29760410
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
44977358
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20949861
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24027497
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17230529
CY2021Q4 us-gaap Goodwill
Goodwill
4799829
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3130215
CY2021Q4 us-gaap Assets
Assets
144438684
CY2020Q4 us-gaap Assets
Assets
129867736
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8976629
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7601123
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1000470
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
872908
CY2021Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
388536
CY2020Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
266667
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9909477
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11460024
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20275112
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20200722
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33037172
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38767167
CY2021Q4 acu Mortgage Payable Non Current
MortgagePayableNonCurrent
11080923
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2364236
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
599280
CY2021Q4 us-gaap Liabilities
Liabilities
67356723
CY2020Q4 us-gaap Liabilities
Liabilities
67151293
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12654787
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
12100663
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
14522178
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7930673
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-825967
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58033252
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
62716443
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129867736
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5065518
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4840571
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55704981
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1040319
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1497258
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1528936
CY2021 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-8515101
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5140578
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6372615
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1161903
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1259079
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1636934
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
59754
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-554681
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1806758
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1815554
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3089045
CY2021 acu Adjustments To Additional Paid In Capital Cash Settlement Of Stock Options
AdjustmentsToAdditionalPaidInCapitalCashSettlementOfStockOptions
342285
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1473444
CY2020 us-gaap Depreciation
Depreciation
2427557
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1490894
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1324423
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
489059
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
60937
CY2021 acu Non Cash Lease Expense
NonCashLeaseExpense
158250
CY2020 acu Non Cash Lease Expense
NonCashLeaseExpense
86042
CY2020 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
526857
CY2021 acu Ppp Loan Forgiveness
PPPLoanForgiveness
3508047
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
7228368
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2028341
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3209330
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10049513
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-159078
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
460179
CY2020 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2617103
CY2020 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-2377730
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5721036
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2569174
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6372615
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13951902
CY2021 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-5729995
CY2020 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
5526760
CY2021 acu Repayments On Mortgage
RepaymentsOnMortgage
3177778
CY2020 acu Repayments On Mortgage
RepaymentsOnMortgage
266667
CY2021 acu Borrowing On Mortgage
BorrowingOnMortgage
11469459
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
1792356
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
1604706
CY2021 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
342285
CY2020 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
1644118
CY2021 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1473444
CY2020 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
286988
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3089045
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
58754
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2042646
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5291082
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-134636
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
285277
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
675973
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2654507
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4167376
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6821883
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4843349
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4167376
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
874996
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
755337
CY2021 us-gaap Interest Paid Net
InterestPaidNet
908781
CY2020 us-gaap Interest Paid Net
InterestPaidNet
930357
CY2021 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Operations</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The operations of Acme United Corporation (the “Company”) consist of three reportable segments. The operations of the Company are structured and evaluated based on geographic location. The three reportable segments operate in the United States (including Asian operations), Canada and Europe. Principal products across all segments are scissors, shears, knives, rulers, pencil sharpeners, first aid safety kits, and related products which are sold primarily to wholesale, contract and retail stationery distributors, office supply super stores, mass market retailers, industrial distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains and wholesale florists.</p>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Estimates<span style="font-style:normal;"> – The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most sensitive and significant accounting estimates relate to customer rebates, valuation allowances for deferred income tax assets, obsolete and slow-moving inventories, potentially uncollectible accounts receivable, intangibles, accruals for income taxes and stock-based compensation. Actual results could differ from those estimates.</span></p>
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-239753
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
96372
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1007187
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1151715
CY2020 acu Cost Of Goods And Services Sold Shipping And Handling
CostOfGoodsAndServicesSoldShippingAndHandling
7486600
CY2021 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P9Y
CY2021 acu Cost Of Goods And Services Sold Shipping And Handling
CostOfGoodsAndServicesSoldShippingAndHandling
10071710
CY2021 us-gaap Advertising Expense
AdvertisingExpense
976268
CY2020 us-gaap Advertising Expense
AdvertisingExpense
1084261
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
40412875
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
40287710
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
88847
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
67208
CY2021Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
13050532
CY2020Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
10349279
CY2021Q4 us-gaap Inventory Net
InventoryNet
53552254
CY2020Q4 us-gaap Inventory Net
InventoryNet
50704197
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1554217
CY2020Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1471925
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration<span style="font-style:normal;"> – The Company performs ongoing credit evaluations of its customers and generally does not require collateral for the extension of credit. Allowances for credit losses are provided and have been within management's expectations. The Company had two customers in 2021 and 2020, respectively, that individually exceeded 10% of consolidated net sales. Net sales to these customers were approximately 17% and 11% of consolidated net sales in 2021 and 18% and 12% in 2020.</span></p>
CY2021Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
379921
CY2020Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
379921
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2271980
CY2020Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2271980
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
663698
CY2020Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
663698
CY2021Q4 acu Finite Lived Fac Gross
FiniteLivedFACGross
1332963
CY2020Q4 acu Finite Lived Fac Gross
FiniteLivedFACGross
1332963
CY2021Q4 acu Finite Lived Med Nap Gross
FiniteLivedMedNapGross
2920145
CY2020Q4 acu Finite Lived Med Nap Gross
FiniteLivedMedNapGross
2920145
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27033828
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27033828
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9803299
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8312405
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17230529
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18721423
CY2021Q4 us-gaap Goodwill
Goodwill
4799829
CY2020Q4 us-gaap Goodwill
Goodwill
4799829
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
22030358
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
23521252
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1490894
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1324423
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1459787
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1455590
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1450400
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1488207
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1447427
CY2021Q4 acu Accrued Customer Rebates
AccruedCustomerRebates
5413829
CY2020Q4 acu Accrued Customer Rebates
AccruedCustomerRebates
6068294
CY2021Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1585938
CY2020Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
3072375
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
457745
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
434546
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
564172
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
459596
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1887793
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1425213
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
9909477
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
11460024
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1727962
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9721756
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2020 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
419298
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
369890
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4980
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
880149
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
153937
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
159909
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
870739
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
788314
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1029656
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1828372
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
401196
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-59801
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
88403
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-40609
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
489599
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-100410
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1519255
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
4524432
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5453178
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5302296
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15174934
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9826728
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2915698
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1864097
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
115855
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
89842
CY2021 acu Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
-1508877
CY2020 acu Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
-99877
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3421
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-126100
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1519255
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1727962
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1916218
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1556398
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1916218
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1556398
CY2021Q4 acu Deferred Tax Assets Asset Valuations
DeferredTaxAssetsAssetValuations
983055
CY2020Q4 acu Deferred Tax Assets Asset Valuations
DeferredTaxAssetsAssetValuations
992101
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
333883
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
454076
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1316938
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1446177
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
599280
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
110221
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
33037172000
CY2021Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
16962828000
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
43214
CY2021 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
342285
CY2020 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
1644118
CY2021 acu Issue Of Shares Related To Settlement Of Share Based Compensation
IssueOfSharesRelatedToSettlementOfShareBasedCompensation
7726
CY2020 acu Issue Of Shares Related To Settlement Of Share Based Compensation
IssueOfSharesRelatedToSettlementOfShareBasedCompensation
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1487925
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1363694
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
299750
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
280750
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5525
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9125
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
245098
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
147394
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1537052
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1487925
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
971568
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
985475
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
18650
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
104372
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
38.38
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.05
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
23.01
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
21.72
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.15
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.51
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.60
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.26
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.33
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
18.99
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1537052
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
971568
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12128507
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6582918
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8098766
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3471374
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3342630
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
483861
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
166867
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3955235
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3509497
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.93
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.42
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.45
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
229250
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
309900
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1987870
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
514271
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
647632
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-825967
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-554681
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1380648
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1265000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1098000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1760000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1128000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
991000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
744000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
644000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
157000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3664000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
300000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1000000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2364000

Files In Submission

Name View Source Status
0001564590-22-012597-index-headers.html Edgar Link pending
0001564590-22-012597-index.html Edgar Link pending
0001564590-22-012597.txt Edgar Link pending
0001564590-22-012597-xbrl.zip Edgar Link pending
acu-10k_20211231.htm Edgar Link pending
acu-10k_20211231_htm.xml Edgar Link completed
acu-20211231.xsd Edgar Link pending
acu-20211231_cal.xml Edgar Link unprocessable
acu-20211231_def.xml Edgar Link unprocessable
acu-20211231_lab.xml Edgar Link unprocessable
acu-20211231_pre.xml Edgar Link unprocessable
acu-ex21_12.htm Edgar Link pending
acu-ex231_7.htm Edgar Link pending
acu-ex311_6.htm Edgar Link pending
acu-ex312_10.htm Edgar Link pending
acu-ex321_8.htm Edgar Link pending
acu-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending